Aggressive NK Cell Leukemia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Registry of the German CLL Study Group
Status:
Recruiting
Last Changed:
Dec 21, 2018
First Changed:
Aug 11, 2016
Disease(s):
CLL
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Status:
Recruiting
Last Changed:
Dec 28, 2018
First Changed:
Jun 20, 2014
Disease(s):
Adult Lymphocyte Depletion Hodgkin Lymphoma
Intervention(s):
6,8-bis(benzylthio)octanoic acidbendamustine hydrochloride
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Active, not recruiting
Last Changed:
Feb 8, 2018
First Changed:
Apr 25, 2013
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
therapeutic allogeneic lymphocyteslaboratory biomarker analysis

Connect. Empower. Inspire.